Reconsidering the rVSVΔG-ZEBOV-GP vaccine during the 2026 Bundibugyo virus outbreak.

Kuppalli K, Lokudu R, Azman AS, Sprecher A, Komanda GM, Ciglenecki I, Albela M, Mukendi D, Boum Y, Nachega JB, Mbala P, Muyembe-Tamfum JJ

Open source

DOI
10.1016/s1473-3099(26)00382-8
Published
2026 Sep
Container
The Lancet. Infectious diseases
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-26-00382-8,
  title = {Reconsidering the rVSVΔG-ZEBOV-GP vaccine during the 2026 Bundibugyo virus outbreak.},
  author = {Kuppalli K and Lokudu R and Azman AS and Sprecher A and Komanda GM and Ciglenecki I and Albela M and Mukendi D and Boum Y and Nachega JB and Mbala P and Muyembe-Tamfum JJ},
  year = {2026},
  journal = {The Lancet. Infectious diseases},
  doi = {10.1016/s1473-3099(26)00382-8},
  url = {https://doi.org/10.1016/s1473-3099(26)00382-8}
}

RIS

TY  - JOUR
TI  - Reconsidering the rVSVΔG-ZEBOV-GP vaccine during the 2026 Bundibugyo virus outbreak.
AU  - Kuppalli K
AU  - Lokudu R
AU  - Azman AS
AU  - Sprecher A
AU  - Komanda GM
AU  - Ciglenecki I
AU  - Albela M
AU  - Mukendi D
AU  - Boum Y
AU  - Nachega JB
AU  - Mbala P
AU  - Muyembe-Tamfum JJ
PY  - 2026
JO  - The Lancet. Infectious diseases
DO  - 10.1016/s1473-3099(26)00382-8
UR  - https://doi.org/10.1016/s1473-3099(26)00382-8
ER  - 

APA

K, K., R, L., AS, A., A, S., GM, K., I, C., M, A., D, M., Y, B., JB, N., P, M., & JJ, M. (2026). Reconsidering the rVSVΔG-ZEBOV-GP vaccine during the 2026 Bundibugyo virus outbreak.. The Lancet. Infectious diseases. https://doi.org/10.1016/s1473-3099(26)00382-8

Source records